+44 1300 500008
Previously it was shown that uncoated lipid nanoparticles of stavudine proved effective in targeting HIV
viral sites in body. Therefore, the main objective of this work was to prepare and characterize surface modified
stavudine entrapped lipid nanoparticles as potential drug delivery system for anti-HIV chemotherapy. The
physical, targeting potential (both in vitro and in vivo) and toxicological evaluation was performed on developed
nanocarriers. The degree of targeting and cellular uptake demonstrated differences among the surface coated
lipid nanoparticles. We found that developed lipid nanoparticles are easy to prepare using high pressure
homogenization, and has excellent stability at room temperature and refrigeration condition. In future, developed surface modified lipid nanoparticles can be evaluated clinically.